Literature DB >> 17586693

Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling.

Kosuke Kato1, Wenju Lu, Hirofumi Kai, K Chul Kim.   

Abstract

MUC1 is a membrane-tethered mucin-like glycoprotein expressed on the surface of various mucosal epithelial cells as well as hematopoietic cells. Recently, we showed that MUC1 suppresses flagellin-induced Toll-like receptor (TLR) 5 signaling both in vivo and in vitro through cross talk with TLR5. In this study, we determined whether phosphoinositide 3-kinase (PI3K), a negative regulator of TLR5 signaling, is involved in the cross talk between MUC1 and TLR5 using various genetically modified epithelial cell lines. Our results showed 1) activation of MUC1 induced recruitment of the PI3K regulatory subunit p85 to the MUC1 cytoplasmic tail (CT) as well as Akt phosphorylation, 2) MUC1-induced Akt phosphorylation required the presence of Tyr(20) within the PI3K binding motif of the MUC1 CT, and 3) mutation of Tyr(20) or pharmacological inhibition of PI3K activation failed to block MUC1-induced suppression of TLR5 signaling. We conclude that whereas PI3K is downstream of MUC1 activation and negatively regulates TLR5 signaling, it is not responsible for MUC1-induced suppression of TLR5 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586693     DOI: 10.1152/ajplung.00423.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  25 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 3.  MUC1 mucin: a peacemaker in the lung.

Authors:  K Chul Kim; Erik P Lillehoj
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

Review 4.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

5.  TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection.

Authors:  Seongwon Choi; Yong Sung Park; Takeshi Koga; Allison Treloar; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

6.  Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae.

Authors:  Yoshiyuki Kyo; Kosuke Kato; Yong Sung Park; Sachin Gajghate; Sachin Gajhate; Tsuyoshi Umehara; Erik P Lillehoj; Harumi Suzaki; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

7.  Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands.

Authors:  Marc A Williams; Stephen Bauer; Wenju Lu; Jia Guo; Scott Walter; Timothy P Bushnell; Erik P Lillehoj; Steve N Georas
Journal:  J Innate Immun       Date:  2009-11-02       Impact factor: 7.349

8.  Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro.

Authors:  Yusheng Li; Darrell L Dinwiddie; Kevin S Harrod; Yong Jiang; K Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-15       Impact factor: 5.464

9.  The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Authors:  Sabine M Ivison; Mohammed A S Khan; Nicholas R Graham; Leila A Shobab; Yu Yao; Arnawaz Kifayet; Laura M Sly; Theodore S Steiner
Journal:  Mediators Inflamm       Date:  2010-10-03       Impact factor: 4.711

10.  MUC1 mucin is a negative regulator of toll-like receptor signaling.

Authors:  Keiko Ueno; Takeshi Koga; Kosuke Kato; Douglas T Golenbock; Sandra J Gendler; Hirofumi Kai; K Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-13       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.